Value Bridge — ERLANGER MEDICAL CENTER
Current $-70M → Target $-46M (+$24.0M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-69.8M
Current EBITDA
$-45.7M
Target EBITDA
+$24.0M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$5.4M
Payer Mix Optimization
$13.1M
Cost to Collect Reduction
$4.4M
Clean Claim Improvement
$3.3M
Volume & Rate Growth
$21.8M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-70M to $-46M. The highest-impact lever is Volume & Rate Growth at $8.7M probability-weighted.
IC talking point: "We see $24M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $265M in equity value creation."